{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:16:17Z","timestamp":1756462577698,"version":"3.41.2"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/igc.0b013e31828f39a0","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T08:42:47Z","timestamp":1368261767000},"page":"785-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Significance of hTERC Gene Detection in Exfoliated Cervical Epithelial Cells for Cervical Lesions"],"prefix":"10.1016","volume":"23","author":[{"given":"Xiuhui","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peihe","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingru","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinhu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanguo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31828f39a0_bb0005","unstructured":"World Health Organization Reproductive Health and Research, Chronic Diseases and Health Promotion. Comprehensive cervical cancer control: a guide to essential practice. Geneva: World Health Organization, 2006."},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/GRF.0b013e31804a8285","article-title":"Cervical cancer screening in the 21st century: is it time to retire the PAP smear?","volume":"50","author":"Wright","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0015","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jnci\/94.18.1406","article-title":"A prospective study of high-grade cervical neoplasia risk among human papillomavirusYinfected women","volume":"94","author":"Castle","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/path.2070","article-title":"Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer","volume":"210","author":"Hopman","year":"2006","journal-title":"J Pathol"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1073\/pnas.93.1.479","article-title":"Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix","volume":"93","author":"Heselmeyer","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y","article-title":"Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q","volume":"19","author":"Heselmeyer","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0035","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/bmj.326.7392.733","article-title":"Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening","volume":"326","author":"Coste","year":"2003","journal-title":"BMJ"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0040","doi-asserted-by":"crossref","first-page":"K42YK52","DOI":"10.1016\/j.vaccine.2008.05.002","article-title":"New technologies in cervical cancer screening","volume":"26","author":"Gravitt","year":"2008","journal-title":"Vaccine"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0045","doi-asserted-by":"crossref","first-page":"56lY567","DOI":"10.1067\/mob.2000.106749","article-title":"A population-based five-year follow-up study of cervical human papillomavirus infection","volume":"183","author":"Elfgren","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0050","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/cncr.10927","article-title":"Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive cytologically negative women","volume":"95","author":"Castle","year":"2002","journal-title":"Cancer"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0055","doi-asserted-by":"crossref","first-page":"S3\/78","DOI":"10.1016\/j.vaccine.2006.05.117","article-title":"Chapter 9: clinical applications of HPV testing: a summary of meta-analyses","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0060","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.297.5581.544","article-title":"Debate surges over the origins of genomic defects in cancer","volume":"297","author":"Marx","year":"2002","journal-title":"Science"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/gcc.1215","article-title":"Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression","volume":"33","author":"Umayahara","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2164-8-53","article-title":"Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer","volume":"8","author":"Kloth","year":"2007","journal-title":"BMC Genomics"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2407-4-5","article-title":"Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma","volume":"4","author":"Rao","year":"2004","journal-title":"BMC Cancer"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0165-4608(01)00510-6","article-title":"Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma","volume":"131","author":"Yang","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/carcin\/bgi218","article-title":"Tetrap loidy and chromosomal instability are early events during cervical carcinogenesis","volume":"27","author":"Olaharski","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/(SICI)1098-2264(199912)26:4<346::AID-GCC9>3.0.CO;2-D","article-title":"Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix","volume":"26","author":"Kersemaekers","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0095","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.onc.1205061","article-title":"Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis","volume":"21","author":"Hackett","year":"2002","journal-title":"Oncogene"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0100","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1101\/gad.12.8.1073","article-title":"The telomerase reverse transcriptase: components and regulation","volume":"12","author":"Nugent","year":"1998","journal-title":"Genes Dev"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0105","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/380079a0","article-title":"Telomerase activation by the E6 gene product of human papillomavirus type 16","volume":"380","author":"Klingelhutz","year":"1996","journal-title":"Nature"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2008.01.040","article-title":"Gain of the 3q26 region in cervicovaginal liquid-based Pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma","volume":"110","author":"Caraway","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0120","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9440(10)63498-0","article-title":"Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia","volume":"163","author":"Heselmeyer-Haddad","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0125","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0002-9440(10)62341-3","article-title":"Genomic amplification of the human telomerase gene (TERC) in Pap smears predicts the development of cervical cancer","volume":"166","author":"Heselmeyer-Haddad","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cancergencyto.2009.01.005","article-title":"Screening of TERC gene amplification as an additional genetic diagnostic test in detection of cervical preneoplastic lesions","volume":"195","author":"Kokalj-Vokac","year":"2009","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0135","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2353\/ajpath.2009.090122","article-title":"Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears","volume":"175","author":"Andersson","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajog.2004.01.043","article-title":"Diagnoses and outcomes in cervical cancer screening: a population-based study","volume":"191","author":"Insinga","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0145","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review","volume":"12","author":"Ostor","year":"1993","journal-title":"Int J Gynecol Pathol"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajog.2007.07.050","article-title":"2006 Consensus guidelines for the management of women with cervical Intraepithelial neoplasia or adenocarcinoma in situ","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bjc.6603253","article-title":"Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas","volume":"95","author":"Andersson","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1097\/IGC.0b013e31828f39a0_bb0160","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.humpath.2009.03.013","article-title":"3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases","volume":"40","author":"Alameda","year":"2009","journal-title":"Hum Pathol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24087723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24087723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e31828f39a0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:18:32Z","timestamp":1753233512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24087723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1048891X24087723"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31828f39a0","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Significance of hTERC Gene Detection in Exfoliated Cervical Epithelial Cells for Cervical Lesions","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31828f39a0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}